---
document_datetime: 2023-09-21 20:32:40
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/ribavirin-teva-pharma-bv-epar-all-authorised-presentations_en.pdf
document_name: ribavirin-teva-pharma-bv-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.7043978
conversion_datetime: 2025-12-21 13:08:11.846798
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| EU Number                                                                                                                                                                                       | Name                                                                                                                                                                                                                                                                                                                                | Strength                                                                            |
|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-------------------------------------------------------------------------------------|
| EU/1/09/527/001 EU/1/09/527/002 EU/1/09/527/003 EU/1/09/527/004 EU/1/09/527/005 EU/1/09/527/006 EU/1/09/527/007 EU/1/09/527/008 EU/1/09/527/009 EU/1/09/527/010 EU/1/09/527/011 EU/1/09/527/012 | Ribavirin Teva Pharma B.V. Ribavirin Teva Pharma B.V. Ribavirin Teva Pharma B.V. Ribavirin Teva Pharma B.V. Ribavirin Teva Pharma B.V. Ribavirin Teva Pharma B.V. Ribavirin Teva Pharma B.V. Ribavirin Teva Pharma B.V. Ribavirin Teva Pharma B.V. Ribavirin Teva Pharma B.V. Ribavirin Teva Pharma B.V. Ribavirin Teva Pharma B.V. | 200 mg 200 mg 200 mg 200 mg 200 mg 200 mg 200 mg 200 mg 400 mg 400 mg 400 mg 400 mg |

blister (PVC/PE/PVAc)

blister (PVC/PE/PVAc)

blister (PVC/PE/PVAc)

blister (PVC/PE/PVAc)

blister (PVC/PE/PVAc)

blister (PVC/PE/PVAc)

blister (PVC/PE/PVAc)

blister (PVC/PE/PVAc)

blister (PVC/PE/PVAc)

blister (PVC/PE/PVAc)

blister (PVC/PE/PVAc)

blister (PVC/PE/PVAc)

blister (PVC/PE/PVAc)

blister (PVC/PE/PVAc)

blister (PVC/PE/PVAc)

## Package size

14 tablets

28 tablets

42 tablets

56 tablets

84 tablets

112 tablets

140 tablets

168 tablets

14 tablets

28 tablets

42 tablets

56 tablets

84 tablets

112 tablets

140 tablets

168 tablets

## Name Strength Pharmaceutical Form Route of Administration Packaging Ribavirin Teva Pharma B.V. 200 mg Film-coated tablet Oral use Ribavirin Teva Pharma B.V. 200 mg Film-coated tablet Oral use Ribavirin Teva Pharma B.V. 200 mg Film-coated tablet Oral use Ribavirin Teva Pharma B.V. 200 mg Film-coated tablet Oral use Ribavirin Teva Pharma B.V. 200 mg Film-coated tablet Oral use Ribavirin Teva Pharma B.V. 200 mg Film-coated tablet Oral use Ribavirin Teva Pharma B.V. 200 mg Film-coated tablet Oral use Ribavirin Teva Pharma B.V. 200 mg Film-coated tablet Oral use Ribavirin Teva Pharma B.V. 400 mg Film-coated tablet Oral use Ribavirin Teva Pharma B.V. 400 mg Film-coated tablet Oral use Ribavirin Teva Pharma B.V. 400 mg Film-coated tablet Oral use Ribavirin Teva Pharma B.V. 400 mg Film-coated tablet Oral use Ribavirin Teva Pharma B.V. 400 mg Film-coated tablet Oral use Ribavirin Teva Pharma B.V. 400 mg Film-coated tablet Oral use Ribavirin Teva Pharma B.V. 400 mg Film-coated tablet Oral use Ribavirin Teva Pharma B.V. 400 mg Film-coated tablet Oral use blister (PVC/PE/PVAc) 1/1 Medicinal product no longer authorised